Eurofins Scientific Acquires Genetic Lab Co.,Ltd. (G Lab) in Japan
December 10, 2021
Eurofins Scientific has entered into a share purchase agreement to acquire Genetic Lab Co.,Ltd. (“G Lab”), a molecular biology-based testing provider in Japan. The acquisition is intended to strengthen Eurofins’ expansion in Asia and enhance its clinical and genetic testing capabilities, including COVID-19 PCR testing and biomarker development support for drug discovery and companion drugs.
- Buyers
- Eurofins Scientific
- Targets
- Genetic Lab Co.,Ltd. (Genetic Lab, “G Lab”)
- Sellers
- Transgenic Inc.
- Industry
- Healthcare Services
- Location
- Japan
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Eurofins (via Eurofins Clinical Testing Lux) Acquires Genetic Testing Service JSC (Gentis) in Vietnam
February 9, 2022
Healthcare Services
Eurofins Scientific, through its subsidiary Eurofins Clinical Testing Lux Sarl, has acquired Genetic Testing Service JSC (Gentis), a market leader in specialised genetic testing in Vietnam. The deal expands Eurofins' footprint in Southeast Asia and strengthens its clinical genetics and advanced molecular diagnostics capabilities in the region.
-
Eurofins Acquires Genetic Testing Service JSC (Gentis) in Vietnam
February 9, 2022
Healthcare Services
Eurofins Scientific, via its subsidiary Eurofins Clinical Testing Lux Sarl, has acquired Genetic Testing Service JSC (Gentis), a leading provider of specialised genetic and clinical testing in Vietnam. The acquisition expands Eurofins' clinical diagnostics footprint in Southeast Asia and adds Gentis' genetic testing capabilities and customer relationships with hospitals and consumers.
-
Eurofins Scientific Acquires Infinity Laboratories
September 16, 2024
Healthcare Services
Eurofins Scientific has completed the acquisition of Infinity Laboratories, a U.S.-based contract testing group that operates eight laboratories and employs approximately 100 staff. The deal expands Eurofins' microbiology and package testing footprint across the United States, enhancing its BioPharma and Medical Device testing capabilities and geographic coverage.
-
Eurofins Agrees to Acquire SYNLAB’s Clinical Diagnostics Operations in Spain
October 28, 2024
Healthcare Services
Eurofins Scientific has reached an agreement with SYNLAB to acquire SYNLAB’s clinical diagnostics operations in Spain. The deal is subject to regulatory approvals and is expected to close in 2025.
-
Eurobio Scientific Acquires GenDx (Genome Diagnostics B.V.)
October 4, 2022
Biotechnology
Paris-based Eurobio Scientific has acquired all outstanding shares of Dutch transplant diagnostics specialist GenDx (Genome Diagnostics B.V.), following a share purchase agreement signed on August 17. The acquisition expands Eurobio's molecular diagnostics portfolio in transplantation and secures the company legacy with proceeds funding a GenDx foundation established by the founders.
-
Eurofins to Acquire DNA Diagnostics Center (DDC) to Expand Consumer Genetic Testing
June 28, 2021
Biotechnology
Eurofins Scientific, via its subsidiary Eurofins Clinical Testing US Holdings, has entered into an agreement to acquire DNA Diagnostics Center (DDC), a consumer-focused DNA testing laboratory. The deal is expected to expand Eurofins’ reach into consumer genetics and health & wellness markets, with DDC projected to generate over $55M in 2021 revenue and operating from its Fairfield, Ohio facility.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.